Category Archives: Events

Latest From Events

#BIO2014 Blogger Roundup

Official Blogger

Want to know what’s happening at the 2014 BIO International Convention? Find out from our bloggers! Small But Tenacious: Two Of San Diego’s Emerging Biotechs, BioSpace AMP-lifying Collaboration at BIO 2014, The Campaign for Modern Medicines BIO Talks Trade, LillyPad CEAPRO receives Canadian Gold Leaf Award for their hard work, Genomics Strongest BIO yet for Lyonbiopole, Genomics Integrated health care can attract biotech to Alberta, Genomics New #BIO2014 Session on Digital Health: Empowering the Healthcare Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Exchange Plans are Helping Patients, But Challenges Remain

Session

After describing many of the benefits the Exchanges have brought to patients—including access to both coverage and federal subsidies—the moderator for the 2014 BIO International Convention breakout session, Impact of Exchanges for Patients, tasked panelists representing a diverse group of stakeholders to describe the challenges that remain for patients enrolled in Exchange plans. These challenges fell into four main categories, including: formulary depth, patient out-of-pocket costs, transparency, and provider networks. In terms of formulary depth, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Access to Big Data

Emerging-Companies115x76

Aquiring information rapidly and reliably reduces costs and advances discovery Sixty years ago, when James Watson and Francis Crick elucidated and published their seminal work on the double helical nature of DNA, they could hardly have imagined the explosion of information about cellular activities and disease pathways happening today. With this explosion, the challenge for scientific database producers is to curate and process the published literature, small molecules, proteins, sequences and numeric data in ways Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Why We Do This Work

rachel-king

In her keynote remarks delivered yesterday at the 2014 BIO International Convention, Rachel King, president & CEO of GlycoMimetics and chairperson of the board of the Biotechnology Industry Organization (BIO), talked about why entrepreneurs pursue opportunities in biotechnology and what sustains these industry leaders through the rollercoaster of raising money, clinical trials, road shows and all the ups and downs of bringing medical innovations from the lab to the bedside. “Working in biotechnology today, we Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Seeing is Believing

brain-scan

PET and MRI imaging helps companies to make go/no go decisions earlier Attrition or failure of new drug programs is a major source of concern, with failure rates ranging from 75 percent in anti-infectives to 92 percent in CNS according to DiMasi’s 2010 study (Clin. Pharmacol. Ther. 87, 272-277). Molecular imaging – both Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) can help improve these dismal statistics. Given the immense costs involved in the Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,